Debating the legalisation of recreational cannabis: The Lancet Regional Health - Europe.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

4 citing papers in PubMed.

1. Ecological momentary insights into cannabis use and its contexts: a pre-post legalization study in Germany.Scientific reports · 2026
   Article
2. Cannabis use is not associated with altered levels of physical activity: evidence from the repeated cross-sectional Belgian Health Interview Survey.Journal of cannabis research · 2025
   Article
3. Cannabis poisonings in Australia following the legalisation of medicinal cannabis, 2014-24: analysis of NSW Poisons Information Centre data.The Medical journal of Australia · 2025
   Article
4. The endocannabinoid system in the brain undergoes long-lasting changes following neuropathic pain.iScience · 2024
   Review

Corrections and comments

• Comment on
  Public health monitoring of cannabis use in Europe: prevalence of use, cannabis potency, and treatment rates.2021

Authors and funding

0 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.